403
Participants
Start Date
February 12, 2024
Primary Completion Date
October 31, 2027
Study Completion Date
April 30, 2028
FMC-376
Oral Capsule
NOT_YET_RECRUITING
Macquarie University, Macquarie Park
NOT_YET_RECRUITING
Eastern Health - Box Hill Hospital, Box Hill
RECRUITING
Tasman Health Care, Southport
RECRUITING
GenesisCare North Adelaide, North Adelaide
NOT_YET_RECRUITING
Icon Cancer Centre Kurralta Park, Kurralta Park
RECRUITING
Linear Clinical Research Ltd, Nedlands
RECRUITING
University of Pennsylvania, Philadelphia
RECRUITING
Virginia Cancer Specialists, Fairfax
RECRUITING
Florida Cancer Specialists and Research Institute, Lake Mary
RECRUITING
Northwest Cancer Centers, Dyer
RECRUITING
Karmanos Cancer Institute, Detroit
RECRUITING
The University of Kansas Cancer Center, Fairway
RECRUITING
The University of Texas MD Anderson Cancer Center, Houston
RECRUITING
Community Clinical Trials, Kingwood
RECRUITING
South Texas Accelerated Research Therapeutics, LLC, San Antonio
RECRUITING
UT Health San Antonio, San Antonio
RECRUITING
START Mountain Region, West Valley City
RECRUITING
University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center, La Jolla
RECRUITING
University of California Irvine (UCI) - Chao Family Comprehensive Cancer Center, Orange
RECRUITING
University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco
RECRUITING
Dana-Farber Cancer Institute, Boston
Lead Sponsor
Frontier Medicines Corporation
INDUSTRY